← Back to Dividend Calendar

Merck & Company Inc

MRKNYSE

HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Market Cap

$285.83B

Revenue (TTM)

$65.01B

EBITDA

$29.11B

Profit Margin

28.1%

P/E Ratio

15.88

Earnings Growth (YoY)

-19.3%

Return on Equity

36.9%

Dividend Yield

2.8%

Upcoming Events (1)Past Events (0)

Earnings Report

Merck & Company

Pre-Market

Report Date:

Fiscal Period:

EPS Estimate:

Rev. Estimate:

Price Target:

Oct 29, 2026

Q3 2026

$2.19(prior yr: $2.58)

$17.3B

$161.24